Number of released MPs from HUVECs and monocytes before and after TNF-α or APC treatment
. | Pretreatment . | After TNF-α treatment . | After APC treatment . |
---|---|---|---|
No. HUVECs | |||
Total MPs | 253 ± 64 | 295 ± 58 | 614 ± 130 |
CD13+ MPs | 203 ± 95 | 221 ± 114 | 509 ± 86 |
EPCR+ MPs | 130 ± 44 | 155 ± 82 | 237 ± 113 |
Monocytes | |||
Total MPs | 278 ± 34 | 341 ± 17 | 410 ± 138 |
CD13+ MPs | 266 ± 48 | 323 ± 21 | 388 ± 125 |
EPCR+ MPs | 156 ± 68 | 168 ± 68 | 189 ± 49 |
. | Pretreatment . | After TNF-α treatment . | After APC treatment . |
---|---|---|---|
No. HUVECs | |||
Total MPs | 253 ± 64 | 295 ± 58 | 614 ± 130 |
CD13+ MPs | 203 ± 95 | 221 ± 114 | 509 ± 86 |
EPCR+ MPs | 130 ± 44 | 155 ± 82 | 237 ± 113 |
Monocytes | |||
Total MPs | 278 ± 34 | 341 ± 17 | 410 ± 138 |
CD13+ MPs | 266 ± 48 | 323 ± 21 | 388 ± 125 |
EPCR+ MPs | 156 ± 68 | 168 ± 68 | 189 ± 49 |
Data indicate the number of MPs (× 103/mL) before and after treatment with TNF-α (10 ng/mL) or APC (100 nM). Data are expressed as mean ± SD.